1094873-17-2

1094873-17-2 structure

Name: (R)-JNJ-31020028
Chemical Name: N-(4-{4-[(1R)-2-(Diethylamino)-2-oxo-1-phenylethyl]-1-piperazinyl}-3-fluorophenyl)-2-(3-pyridinyl)benzamide
CAS Number: 1094873-17-2
Molecular Formula: C₃₄H₃₆FN₅O₂
Molecular Weight: 565.680
Catalog: Signaling Pathways GPCR/G Protein Neuropeptide Y Receptor
Create Date: 2018-07-06 08:15:20
Modify Date: 2024-01-10 10:06:54
(R)-JNJ-31020028 is a high affinity, selective brain penetrant neuropeptide Y Y2 receptor antagonist, with pIC50 values of 8.07, 8.22 and 8.21 for human, rat, and mouse Y2 receptor, respectively. (R)-JNJ-31020028 shows >100-fold selective versus human Y1, Y4, and Y5 receptors. (R)-JNJ-31020028 has antidepressant like effects[1][2].

Name	N-(4-{4-[(1R)-2-(Diethylamino)-2-oxo-1-phenylethyl]-1-piperazinyl}-3-fluorophenyl)-2-(3-pyridinyl)benzamide
Synonyms	1-Piperazineacetamide, N,N-diethyl-4-[2-fluoro-4-[[2-(3-pyridinyl)benzoyl]amino]phenyl]-α-phenyl-, (αR)- N-(4-{4-[(1R)-2-(Diethylamino)-2-oxo-1-phenylethyl]-1-piperazinyl}-3-fluorophenyl)-2-(3-pyridinyl)benzamide MFCD29477347

Description	(R)-JNJ-31020028 is a high affinity, selective brain penetrant neuropeptide Y Y2 receptor antagonist, with pIC50 values of 8.07, 8.22 and 8.21 for human, rat, and mouse Y2 receptor, respectively. (R)-JNJ-31020028 shows >100-fold selective versus human Y1, Y4, and Y5 receptors. (R)-JNJ-31020028 has antidepressant like effects[1][2].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> Neuropeptide Y Receptor
Target	human Y2 receptor:8.07 (pIC50) rat Y2 receptor:8.22 (pIC50) mouse Y2 receptor:8.21 (pIC50)
In Vivo	(R)-JNJ-31020028 (5.6 μg; chronic icv infusion; daily for 10 days) has antidepressant like effects in the olfactory bulbectomized rat (OBX) model[1]. Chronic icv administration of (R)-JNJ-31020028 at 5.6 μg/day using osmotic Alzet pump resulted in a significant decreases number of grooming events[1]. (R)-JNJ-31020028 treatment shows the Cmax, Tmax , AUCinf, Vd, and t1/2 were 4.35 μM, 0.5 hours, 7.91 h μM and 0.83 hours, respectively[1]. Animal Model: Male Sprague Dawley rats weighing 150-170 (OBX model)[1] Dosage: 5.6 μg Administration: chronic icv infusion; daily for 10 days Result: Reduced OBX rat immobility time. Animal Model: male Sprague-Dawley rat[2] Dosage: 10 mg/kg Administration: s.c. (Pharmacokinetic Analysis) Result: The Cmax, Tmax , AUCinf, Vd, and t1/2 were 4.35 μM, 0.5 hours, 7.91 h μM and 0.83 hours, respectively.
References	[1]. Shoblock JR, et al. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology (Berl). 2010 Feb;208(2):265-77. [2]. Morales-Medina JC, et al. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Neuropeptides. 2012 Dec;46(6):329-34.

Density	1.2±0.1 g/cm3
Boiling Point	677.5±55.0 °C at 760 mmHg
Molecular Formula	C₃₄H₃₆FN₅O₂
Molecular Weight	565.680
Flash Point	363.5±31.5 °C
Exact Mass	565.285278
LogP	5.23
Vapour Pressure	0.0±2.1 mmHg at 25°C
Index of Refraction	1.628

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1094873-17-2	1094873-14-9
1391481-68-7	73981-53-0
1391485-18-9	66423-07-2
1213878-29-5	528566-21-4
2242647-55-6	1640848-93-6
2228349-55-9	2229609-52-1
2229366-72-5	2227774-44-7
2229305-24-0	2228222-51-1
2229609-57-6	2228734-86-7
2648895-34-3	2229461-99-6